Example Deal

Walk through an illustrative deal, end to end.

Atlas Clinical AI is an illustrative company, not a customer reference or investment recommendation. It shows how MindLab moves from source materials to first read, review flags, memo language, approval, and company record.

Example Deal

Atlas Clinical AI walkthrough
Example

Source set

PDFSeries B deck18 claims
XLSModel v127 assumptions
DOCFounder call notes9 follow-ups
MEMO2024 healthcare AI thesis3 criteria

Workflow path

01

Source room

Deck, model, call notes, board update, and prior memo loaded

02

First read

Claims, figures, risks, and missing information extracted

03

Conflicts

Sales hiring and expansion revenue assumptions flagged

04

Memo section

Risk language drafted with source links and reviewer notes

05

Approval

Partner edits decide what is final, draft, or blocked

06

Record

Approved assumptions and open questions saved for the next review

This walkthrough is designed to show product behavior: how source coverage, conflicts, reviewer decisions, and approved memory would move through a real investment workflow.

Source Set

Load the materials once. Keep every output tied to the same evidence.

Pitch deck

Market, product, ARR, customer claims

Financial model

Revenue bridge, margin assumptions, hiring plan

Founder call notes

Expansion story, objections, open asks

Prior thesis memo

Firm criteria, rejected comparables, hard-pass logic

First Read

The first pass should make review easier, not hide the hard questions.

MindLab prepares the brief, but the important part is the review surface: what is supported, what conflicts, what is missing, and what needs a human decision.

Supported claim

Gross margin above 70% appears in both the model and founder call notes.

Conflict flagged

The board update and model disagree on 2026 sales hiring assumptions.

Missing evidence

Expansion revenue depends on three enterprise customers without cohort-level NRR detail.

Review Loop

Draft the memo section. Keep the reviewer in control.

Source-linked language moves faster through review because partners can challenge the underlying claim, not just the sentence.

Source Review

Atlas Clinical AI diligence
Partner review active

Inputs

Series B deck

18

18 deal claims linked

Model v12

Flag

Revenue bridge reconciled

Partner notes

4

4 objections preserved

Review Workspace

Draft claim

Expansion depends on reducing clinical onboarding time below 21 days.

Supported

Deck p.14, call note 05

Needs Review

Cohort data requested

Reviewer edits decide what gets saved, what stays draft, and what gets blocked.

Approved Record

Company Record

Partner-approved thesis

Enterprise clinical teams show stronger pull than SMB practices.

Open diligence question

Validate churn assumptions in hospital expansion cohort.

Comparable pattern

Similar buyer-risk pattern seen in rejected RPM review.

Outputs

One deal review creates the next starting point.

Diligence brief

Claims, risks, missing information, and follow-up questions prepared for review.

IC memo risk section

Draft language tied to source citations, reviewer notes, and blocked claims.

Company record

Approved assumptions, objections, source links, and open questions saved for later.

Pilot Scorecard

What the first workflow should prove.

The scorecard shows the kind of evidence a first workflow should produce: source coverage, conflicts found, reviewer confidence, and approved context saved.

Pilot Scorecard

Atlas IC memo workflow
Example

42

claims linked to source

6

conflicts surfaced

3

outputs drafted

19

approved record items

Evidence areas

Evidence coverage91%

Deck, model, call notes, and prior memo connected

Reviewer confidence84%

Unsupported claims blocked before memo export

Reuse value76%

Approved assumptions saved for the next review

Pilot decision

Continue

Memo risk section met review standard

Expand

Add portfolio update workflow next

Preserve

Approved assumptions saved to record

Trust Console

Atlas Clinical AI workspace
External boundary active
Knowledge setUseStatus

Internal workspace

Full source room, notes, partner debate

Internal only

Set

Approved records

Saved decisions and reviewer notes

Approval gate

Set

External advisor

Approved facts only

Restricted answer

Set

Unsupported claim

No source or weak evidence

Blocked

Set

Current external response

12 approved facts available. Internal notes, valuation debate, and partner comments blocked.

The public-safe answer is not the internal record.

In this example, internal partner debate and valuation notes stay blocked from external responses. Approved facts can be reused. Sensitive working notes stay internal.

Internal notes stay internal
Unsupported claims are blocked
Approved facts can power advisor-style responses

Next Step

Bring us the workflow that needs a better first pass.

We can map one source set, one review standard, and one useful output before requesting broad confidential materials.

Scope a first workflow